APA (7th ed.) Citation

Z, W., Q, H., J, Z., Z, L., F, J., B, Y., . . . Y, Z. (2026). LSD1-GLS2 axis drives subtype-specific chemoresistance in pancreatic cancer through glutaminolysis reprogramming. Cell death & disease, 17(1), . https://doi.org/10.1038/s41419-026-09075-4

Chicago Style (17th ed.) Citation

Z, Wang, et al. "LSD1-GLS2 Axis Drives Subtype-specific Chemoresistance in Pancreatic Cancer Through Glutaminolysis Reprogramming." Cell Death & Disease 17, no. 1 (2026). https://doi.org/10.1038/s41419-026-09075-4.

MLA (9th ed.) Citation

Z, Wang, et al. "LSD1-GLS2 Axis Drives Subtype-specific Chemoresistance in Pancreatic Cancer Through Glutaminolysis Reprogramming." Cell Death & Disease, vol. 17, no. 1, 2026, https://doi.org/10.1038/s41419-026-09075-4.